Qomolangma Acquisition Corp. Common Stock

NASDAQ:QOMO USA Shell Companies
Market Cap
$28.88 Million
Market Cap Rank
#29202 Global
#9687 in USA
Share Price
$11.55
Change (1 day)
+0.00%
52-Week Range
$11.55 - $11.55
All Time High
$12.65
About

Qomolangma Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire businesses in the internet and high technology, financial technology, clean energy, agriculture machinery, health care, consumer a… Read more

Qomolangma Acquisition Corp. Common Stock (QOMO) - Net Assets

Latest net assets as of June 2024: $4.34 Million USD

Based on the latest financial reports, Qomolangma Acquisition Corp. Common Stock (QOMO) has net assets worth $4.34 Million USD as of June 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($9.48 Million) and total liabilities ($5.14 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $4.34 Million
% of Total Assets 45.78%
Annual Growth Rate 490.57%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 116061.35

Qomolangma Acquisition Corp. Common Stock - Net Assets Trend (2021–2024)

This chart illustrates how Qomolangma Acquisition Corp. Common Stock's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Qomolangma Acquisition Corp. Common Stock (2021–2024)

The table below shows the annual net assets of Qomolangma Acquisition Corp. Common Stock from 2021 to 2024.

Year Net Assets Change
2024-12-31 $4.34 Million 0.00%
2023-12-31 $4.34 Million -91.63%
2022-12-31 $51.87 Million +246157.47%
2021-12-31 $21.07K --

Equity Component Analysis

This analysis shows how different components contribute to Qomolangma Acquisition Corp. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 447944400.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $8.83 Million 203.20%
Total Equity $4.34 Million 100.00%

Qomolangma Acquisition Corp. Common Stock Competitors by Market Cap

The table below lists competitors of Qomolangma Acquisition Corp. Common Stock ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Qomolangma Acquisition Corp. Common Stock's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 4,344,241 to 4,344,241, a change of 0 (0.0%).
  • Net loss of 138,905 reduced equity.
  • Share repurchases of 46,921,772 reduced equity.
  • Other factors increased equity by 47,060,677.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-138.91K -3.2%
Share Repurchases $46.92 Million -1080.09%
Other Changes $47.06 Million +1083.29%
Total Change $- 0.00%

Book Value vs Market Value Analysis

This analysis compares Qomolangma Acquisition Corp. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 14.33x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 3597.14x to 14.33x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2021-12-31 $0.00 $11.55 x
2022-12-31 $19.43 $11.55 x
2023-12-31 $1.74 $11.55 x
2024-12-31 $0.81 $11.55 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Qomolangma Acquisition Corp. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -3.20%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 2.16x
  • Recent ROE (-3.20%) is above the historical average (-6.20%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2021 -18.68% 0.00% 0.00x 13.65x $-6.04K
2022 0.26% 30.81% 0.01x 1.05x $-5.05 Million
2023 -3.20% 0.00% 0.00x 2.16x $-573.33K
2024 -3.20% 0.00% 0.00x 2.16x $-573.33K

Industry Comparison

This section compares Qomolangma Acquisition Corp. Common Stock's net assets metrics with peer companies in the Shell Companies industry.

Industry Context

  • Industry: Shell Companies
  • Average net assets among peers: $-56,363,212
  • Average return on equity (ROE) among peers: -7.18%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Qomolangma Acquisition Corp. Common Stock (QOMO) $4.34 Million -18.68% 1.18x $8.60 Million
Artius II Acquisition Inc. Class A Ordinary Shares (AACB) $-60.27K 0.00% 0.00x $198.37 Million
Artius II Acquisition Inc. Units (AACBU) $-60.27K 0.00% 0.00x $205.28 Million
Ares Acquisition Corporation II (AACT-UN) $-22.04K 0.00% 0.00x $399.77 Million
AA Mission Acquisition Corp. (AAM-UN) $-559.90 Million 0.00% 0.00x $349.76 Million
Global Acquisitions Corporation (AASP) $5.32 Million -71.85% 3.84x $15.42 Million
ABV Consulting Inc (ABVN) $-185.37K 0.00% 0.00x $461.96K
Atlantic Coastal Acquisition Corp II (ACAB) $-8.52 Million 0.00% 0.00x $2.44 Million
Annabidiol Corp (ACBD) $-181.19K 0.00% 0.00x $14.73K
ACRO Biomedical Co Ltd (ACBM) $-14.79K 0.00% 0.00x $30.04K
Huaizhong Health Group Inc (ADAD) $-1.02K 0.00% 0.00x $3.15K